Less Ads, More Data, More Tools Register for FREE

Pin to quick picksStaffline Regulatory News (STAF)

Share Price Information for Staffline (STAF)

Share Price is delayed by 15 minutes
Get Live Data
41.65    -0.35 (-0.83%)
Bid:
41.00
Ask:
42.30
Spread: 1.30 (3.171%)
Market Cap: £45.95m
STAF Live PriceLast checked at - London Stock Exchange

Intraday Staffline Share Chart

Customer Win

22 Mar 2022 07:01

RNS Number : 5260F
Staffline Group PLC
22 March 2022
 

22 March 2022

Staffline Group plc

("Staffline", the "Company" or the "Group")

 

Customer Win

 

New long term agreement secured with major automotive manufacturer

 

Staffline (AIM: STAF), the recruitment and training group, is pleased to announce that its Recruitment GB division has, subject to contract, successfully secured a long-term agreement with BMW Group (BMW, MINI and Rolls-Royce Motor Cars) to supply the flexible operational workforces and a number of specialist roles for its manufacturing sites in England.

 

It is anticipated that the contract will commence in Q2 2022 and BMW Group will become one of Staffline's top 5 clients. Management also believes that this contract, combined with the notable increases in demand that are evident across Staffline's core automotive and automotive supply chain services, will see the Group's activity within this segment return to pre-pandemic levels from H2 2022 onwards.

 

Albert Ellis, Chief Executive Officer of Staffline, commented:

 

"We are delighted to have secured such a strategically important contract for the Group, not just because we expect BMW to become a key customer, but also as it provides material evidence of resurgence in a sector which historically has been an important growth engine for our business."

 

"This win, alongside the strong pipeline of opportunities currently being pursued across the Group, is further evidence of our strategy to leverage our strengthened financial position and continue to expand our operational footprint to grow market share in action and underpins expectations for the year."

 

The information contained within this announcement is deemed by the Company to constitute inside information as stipulated under the Market Abuse Regulation (EU) No. 596/2014 as amended by The Market Abuse (Amendment) (EU Exit) Regulations 2019. Upon the publication of this announcement via the Regulatory Information Service, this inside information is now considered to be in the public domain.

 

For further information, please contact:

 

Staffline Group plc

www.stafflinegroupplc.co.uk

Albert Ellis, Chief Executive Officer

Daniel Quint, Chief Financial Officer

via Vigo Consulting

Liberum (Nominated Adviser and Broker)

www.liberum.com

Richard Lindley / William Hall / Christopher Whitaker

020 3100 2222

Vigo Consulting (Financial PR)

www.vigoconsulting.com

Jeremy Garcia / Antonia Pollock / Kate Kilgallen

020 7390 0230

Staffline@vigoconsulting.com

 

 

About Staffline

 

Providing workforce solutions

Staffline is the UK's market leading Recruitment and Training group. It has three divisions:

 

Recruitment GB

Staffline is a leading provider of flexible blue-collar workers, supplying c.33,000 staff per day on average from around 420 client sites, across a wide range of industries including agriculture, supermarkets, drinks, driving, food processing, logistics and manufacturing.

 

Recruitment Ireland

The Recruitment Ireland business is a leading end to end solutions provider operating across twenty industries, ten branch locations and ten onsite customer locations, supplying c.4,500 staff per day on average, and offering RPO, MSP, temporary and permanent solutions across the island of Ireland

 

PeoplePlus Division

PeoplePlus is leading skills and employability business with a clear purpose to help people transform their lives, get jobs and keep jobs, and develop their careers. The division works with employers to develop workforces of the future, and with central, local and devolved governments to support their economic and social policy agendas

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
CNTUAVURUWUOUUR
Date   Source Headline
21st Mar 20237:00 amRNS2022 Audited Results
8th Mar 20237:00 amRNSAnalyst & Investor Presentation
1st Mar 20234:35 pmRNSPrice Monitoring Extension
20th Feb 20234:43 pmRNSDirector/PDMR Shareholding
20th Feb 202312:48 pmRNSEBT Share Purchase
17th Feb 20237:01 amRNSDirector/PDMR Shareholding
17th Feb 20237:00 amRNSGrant of Options under 2023 LTIP
13th Feb 202310:50 amRNSReplacement: Director/PDMR Shareholding
10th Feb 202312:25 pmRNSDirector/PDMR Shareholding
10th Feb 20237:00 amRNSDirector/PDMR Shareholding
8th Feb 20237:20 amRNSDirector/PDMR Shareholding
6th Feb 20234:40 pmRNSSecond Price Monitoring Extn
6th Feb 20234:35 pmRNSPrice Monitoring Extension
2nd Feb 20232:01 pmRNSDirector/PDMR Shareholding
27th Jan 20237:00 amRNSDirector/PDMR Shareholding
26th Jan 20233:45 pmRNSEBT Share Purchase
26th Jan 202311:59 amRNSDirector/PDMR Shareholding
25th Jan 202311:28 amRNSDirector/PDMR Shareholding
24th Jan 20237:00 amRNSTrading Update & Notice of Results
19th Jan 20237:00 amRNSAppointment of Joint Broker
13th Jan 20237:00 amRNSNotice of Trading Update & Investor Presentation
23rd Dec 20229:44 amRNSDirector/PDMR Shareholding
6th Dec 20227:00 amRNSDirector/PDMR Shareholding
17th Nov 20227:00 amRNSBoard Update
11th Nov 202210:18 amRNSDirector/PDMR Shareholding
9th Nov 20224:26 pmRNSGrant of Options under SAYE Scheme
31st Oct 202212:00 pmRNSDirector/PDMR Shareholding
18th Oct 20225:04 pmRNSDirector/PDMR Shareholding
10th Oct 202210:20 amRNSEBT Share Purchase
3rd Oct 20224:53 pmRNSDirector/PDMR Shareholding
3rd Oct 20227:03 amRNSDirector Declaration
27th Sep 20222:06 pmRNSDirector/PDMR Shareholding
18th Aug 20222:26 pmRNSDirector/PDMR Shareholding
15th Aug 202210:04 amRNSDirector/PDMR Shareholding
11th Aug 20227:01 amRNSDirector/PDMR Shareholding
11th Aug 20227:00 amRNSDirector/PDMR Shareholding
10th Aug 20227:00 amRNSDirector/PDMR Shareholding
9th Aug 202211:21 amRNSTotal Voting Rights
9th Aug 202211:20 amRNSHolding(s) in Company
9th Aug 20227:00 amRNSDirector/PDMR Shareholding
3rd Aug 20226:29 pmRNSDirector/PDMR Shareholding
2nd Aug 20226:18 pmRNSEBT Share Purchase
2nd Aug 20227:01 amRNSNew Contract Win
2nd Aug 20227:00 amRNSUnaudited Interim Results
13th Jul 20227:00 amRNSNotice of Results and Investor Presentation
5th Jul 20225:38 pmRNSHolding(s) in Company
5th Jul 20223:47 pmRNSHolding(s) in Company
26th May 20221:31 pmRNSResult of 2022 Annual General Meeting
26th May 20227:00 amRNSAGM Trading Update and Board Changes
25th May 20227:00 amRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.